RxDoctor Payments Data

Mary Leemputte, MD

Interventional Pain Medicine · Grand Rapids, MINPI 1043673320

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 38.7% of the total. 2025 is the largest year on record at $3,260, 3.6 times the $915 reported in 2020.

$7,793in general payments, 2019–2025

Across 75 payments — averaging $103.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Boston Scientific$3K
  • Medtronic$788
  • Curonix LLC$465
  • SPR Therapeutics, Inc$283
  • Nevro Corp.$206
  • plus $308 from 9 others

What the payments were for

  • Travel & lodging$4,51858%
  • Food & beverage$3,23742%
  • Education$370%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,793 in reported general payments places this provider in the 75th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$57,470
Medicare patients
146
Services billed
1,604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen181$4,675
Gabapentin349$3,963
Pregabalin226$3,364
Tizanidine Hcl245$2,456
Cyclobenzaprine Hcl122$929
Baclofen44$842
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$656
Diclofenac Sodium24$574
Duloxetine Hcl33$553
Morphine Sulfate ErMorphine Sulfate26$454
Celecoxib17$349
Methocarbamol17$221
Methylprednisolone19$157
Naproxen14$123
Diazepam111$88

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →